Nizoral Korpásodás Ellen (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of the fungal cell membrane. Without ergosterol, the membrane becomes defective, leading to impaired growth and death of the fungus.

The specific dosing regimen for Nizoral Korpásodás Ellen is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and other clinical factors. Patients should follow the prescriber’s instructions exactly.

Safety data for topical ketoconazole during pregnancy or lactation are limited. Healthcare providers usually weigh the potential benefits against any possible risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their doctor.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoconazole belongs to the azole class, which differs from allylamine agents such as terbinafine. Azoles have a broad spectrum against yeasts and dermatophytes and are often preferred for scalp conditions, while allylamines may be more effective for certain nail infections. Choice depends on infection type, site and physician preference.

Store the product at room temperature, ideally below 25 °C. Keep it in the original packaging, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

The medication is applied topically to the affected skin or scalp. Clean and dry the area, then spread a thin layer of the cream or lotion as directed by the prescriber, usually once or twice daily, and allow it to dry before covering the area.

Serious risks include allergic contact dermatitis, severe skin reactions such as blistering or ulceration, and, rarely, systemic absorption leading to liver enzyme abnormalities. Patients should stop use and seek medical attention if they notice extensive rash, swelling, or signs of systemic toxicity.

Individuals with a known hypersensitivity to ketoconazole, other azole antifungals, or any component of the formulation should avoid using the product. It is also contraindicated on severely damaged or broken skin unless specifically advised by a healthcare professional.